DNV certifies Cowellmedi under the EU Medical Device Regulation (MDR)

DNV supports the dental implant manufacturer in demonstrating compliance with the strengthened requirements of the EU Medical Device Regulation (MDR).

DNV has awarded EU Medical Device Regulation (MDR) certification to Korean dental implant manufacturer Cowellmedi. The certificate was presented during a ceremony held on 28 April by Cecilie Gudesen Torp, Global Director Medical Services and Managing Director, DNV Product Assurance AS. The certification confirms that Cowellmedi’s products and quality management system comply with the strengthened requirements of the EU MDR.

The EU MDR framework has substantially raised regulatory expectations for demonstrating the safety and performance of medical devices. Since its implementation, manufacturers have been required to establish more robust clinical evidence, risk management, and post-market surveillance processes, while Notified Body assessment criteria have also become more stringent.

The certification covers Cowellmedi’s key implant system product portfolio, including its proprietary surface treatment technology “HydroX7”, next-generation implant systems, and related surgical instruments. Major product lines including “INNO X”, “INNO V”, and “INNO Z” were also included within the certification scope.

The CE MDR certification formally recognizes that Cowellmedi’s products and quality management system meet the strengthened EU regulatory requirements. In addition to supporting access to the European market, CE MDR certification is also widely recognized across global export markets, including the Middle East and Southeast Asia, as an important indicator of product quality and regulatory compliance capability.